N. Shankar Revised's most recent trade in Pharmaids Pharmaceuticals Ltd. was a Acquisition of 100,000 Equity Shares done at an average price of Rs. 35 . Disclosure was reported to the exchange on Sept. 15, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for N. Shankar Revised in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaids Pharma | SHANKARAPPA NAGARAJA VINAYA BABU (Revised) | Director | Acquisition | 15 Sep 2025 | 100,000 | 9,831,064 (27.88%) | 0.28% | 35 | 3,500,000 | 09 Sep 2025 09 Sep 2025 |
Insider Trading | Equity Shares | Off Market |
| Coromandel | N. Shankar (Revised) | Designated Person | Disposal | 16 Jul 2021 | 3,300 | 14,930 (0.01%) | 0.00% | 753.9 | 2,488,021 | 19 Mar 2021 19 Mar 2021 |
Insider Trading | Equity Shares | Market Sale |
| Coromandel | N. Shankar (Revised) | Designated Person | Revoke | 16 Jul 2021 | 3,300 | 18,230 (0.01%) | 0.00% | 747.6 | 2,466,915 | 19 Mar 2021 19 Mar 2021 |
Insider Trading | Equity Shares | Revocation Of Pledge |
| Coromandel | N. Shankar (Revised) | Designated Person | Disposal | 16 Jul 2021 | 1,000 | 18,230 (0.01%) | 0.00% | 775.6 | 775,600 | 16 Mar 2021 16 Mar 2021 |
Insider Trading | Equity Shares | Market Sale |
| Coromandel | N. Shankar (Revised) | Designated Person | Disposal | 16 Jul 2021 | 200 | 19,230 (0.01%) | 0.00% | 776 | 155,200 | 08 Mar 2021 08 Mar 2021 |
Insider Trading | Equity Shares | Market Sale |